Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/cid/ciaa1474 http://scihub22266oqcxt.onion/10.1093/cid/ciaa1474 32986807!7543308!32986807     free     free     free       Clin+Infect+Dis 2021 ; 73 (7): e1762-e1765 Nephropedia Template TP {{tp|p=32986807|t=2021. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019 |pdf=|usr=}}{{32986807}} gab.com Text Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019 JO: Clin Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32986807 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly discovered virus for which remdesivir is the only antiviral available. We report the occurrence of a mutation in RdRP (D484Y) following treatment with remdesivir in a 76-year-old female with post-rituximab B-cell immunodeficiency and persistent SARS-CoV-2 viremia. A cure was achieved after supplementation with convalescent plasma. Twit Text FOAVip Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019 ????Clin Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32986807 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32986807 #FOAvip English Wikipedia <ref>{{Cite pmid|32986807}}</ref> Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019 #MMPMID32986807 Martinot M; Jary A; Fafi-Kremer S; Leducq V; Delagreverie H; Garnier M; Pacanowski J; Mekinian A; Pirenne F; Tiberghien P; Calvez V; Humbrecht C; Marcelin AG; Lacombe K Clin Infect Dis 2021[Oct]; 73 (7): e1762-e1765 PMID32986807show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly discovered virus for which remdesivir is the only antiviral available. We report the occurrence of a mutation in RdRP (D484Y) following treatment with remdesivir in a 76-year-old female with post-rituximab B-cell immunodeficiency and persistent SARS-CoV-2 viremia. A cure was achieved after supplementation with convalescent plasma. |*COVID-19 Drug Treatment[MESH] |*COVID-19/therapy[MESH] |*RNA-Dependent RNA Polymerase[MESH] |Adenosine Monophosphate/analogs & derivatives[MESH] |Aged[MESH] |Alanine/analogs & derivatives[MESH] |B-Lymphocytes[MESH] |COVID-19 Serotherapy[MESH] |Female[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Mutation[MESH]Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated(epmc).pdf DeepDyve Pubget Overpricing